It's about time to write off high-growth tech stocks, Goldman warned, saying software carries the highest multiples since the tech bubble.Marketsread more
Iran will surpass the internationally agreed levels of its low-enriched uranium levels in 10 days, the country's atomic energy body said Monday.Politicsread more
Boeing said the airline industry will need 44,040 new commercial airplanes by 2038. The market value of those planes would reach $6.8 trillion, up from $6.49 trillion...Airlinesread more
Sotheby's announces it has signed an agreement to be acquired by BidFair USA, a venture owned by art collector Patrick Drahi.Marketsread more
Apple is reportedly building three new iPhones for 2020, including two with 5G. It may also slightly change the screen sizes of the new iPhones.Technologyread more
Overall, extortion by email is growing significantly, according to the FBI's Internet Crime Compliant Center (IC3). Last year, these complaints rose 242% to 51,146 reported...Technologyread more
Target's nationwide cash register meltdown over the weekend created more than $16 million in buzz on the internet from news reports and other social media mentions, according...Retailread more
The chipmaker crush could persist and investors should be selective, but Nvidia looks like a clear buy, one market watcher says.Trading Nationread more
The top court scrapped a ruling from the Oregon Court of Appeals in favor of the same-sex couple. The owners of the bakery, which refused the make the cake due to religious...Politicsread more
Amazon responded this morning to Democratic Congresswoman Alexandria Ocasio-Cortez's claim that it pays warehouse workers "starvation wages" in a tweet that says it pays...Technologyread more
The nation's homebuilders reported solid confidence in the housing market in June, but levels dropped slightly due to concerns over trade issues, the high costs of...Real Estateread more
Medicines in development at Biogen and Eli Lilly could be the first to slow the cognitive declines brought by Alzheimer's disease. New data will be presented Wednesday at the Alzheimer's Association International Conference in Washington, D.C. So how do they work?
The drugs take aim at the plaque buildups in the brain that characterize Alzheimer's, known as beta amyloid. Unlike currently marketed drugs Aricept and Namenda, which affect levels of certain brain chemicals and may temporarily ease symptoms of Alzheimer's, Biogen's and Lilly's drugs may be disease modifying.
Read More The next trigger for Biogen shares
They're important because they have instilled new confidence in what's known as the amyloid hypothesis: the idea that targeting those plaque buildups will actually slow the disease.
The medicines bind to beta amyloid in slightly different ways, but both companies are treating patients in the earlier stages of Alzheimer's disease. It's thought that additional methods will be needed to help patients who have cases that are more advanced.
Other approaches include targeting tangles of proteins known as tau, and reducing the production of beta amyloid in the first place by inhibiting an enzyme known as beta secretase.
Read MoreBreakthrough in Parkinson's